Abstract
The promising field of regenerative medicine is thrilling as it can repair and restore organs for various debilitating diseases. Mesenchymal stem cells are one of the main components in regenerative medicine that work through the release of secretomes. By adopting the use of the secretome in cell-free-based therapy, we may be able to address the challenges faced in cell-based therapy. As one of the components of cell-free-based therapy, secretome has the advantage of a better safety and efficacy profile than mesenchymal stem cells. However, secretome has its challenges that need to be addressed, such as its bioprocessing methods that may impact the secretome content and its mechanisms of action in clinical settings. Effective and standardization of bioprocessing protocols are important to ensure the supply and sustainability of secretomes for clinical applications. This may eventually impact its commercialization and marketability. In this review, the bioprocessing methods and their impacts on the secretome profile and treatment are discussed. This improves understanding of its fundamental aspects leading to potential clinical applications.
Similar content being viewed by others
Data availability
Not applicable.
Abbreviations
- Alg:
-
Alginate
- ALI-model:
-
Acute lung injury mice model
- ANGPT1:
-
Angiopoietin-1
- ASC-CCM:
-
Adipose-derived stem cell concentrated conditioned medium
- ASC-S:
-
Adipose tissue-derived stromal cell secretome
- AST-ST:
-
Hypoxic cultured adipose-derived mesenchymal stem cell secretome
- BDNF:
-
Brain-derived neurotrophic factor
- bFGF:
-
Basic fibroblast growth factor
- CG:
-
Carrageenan
- Ch:
-
Chitosan
- CM:
-
Conditioned media
- CNTF:
-
Ciliary neurotrophic factor
- COPD:
-
Chronic obstructive pulmonary disease
- COX2:
-
Cyclooxygenase 2
- CRD:
-
Chronic respiratory disease
- CS:
-
Chondroitin sulfate
- CTGF:
-
Connective tissue growth factor
- CXCL:
-
C-X-C motif chemokine ligand
- DCM:
-
Dilated cardiomyopathy
- dECM:
-
Cardiac decellularized extracellular matrix
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- ECM:
-
Extracellular matrix
- EF-2:
-
Eukaryotic elongation factor 2
- EGF:
-
Epidermal growth factor
- EPO:
-
Erythropoietin
- EPOR:
-
Erythropoietin receptor
- EV:
-
Extracellular vesicle
- FBS:
-
Fetal bovine serum
- FDA:
-
US Food and Drug Administration
- FGF:
-
Fibroblast growth factor
- FLT-3:
-
Fms-related tyrosine kinase 3
- Gal:
-
Galectin
- GDNF:
-
Glial cell-derived neurotrophic factor
- GDNF:
-
Glial-derived neurotrophic factor
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor
- GMP:
-
Good manufacturing practice TGF-β1
- HA:
-
Hyaluronic acid
- HGF:
-
Hepatocyte growth factor
- HGF:
-
Hepatocyte growth factor
- HLA-1:
-
Human leukocyte antigen 1
- HLA-G5:
-
Human leukocyte antigen G5
- hNPC:
-
Human neural precursor cells
- HO-1:
-
Heme oxygenase-1
- hPL:
-
Human platelet lysate
- Hypo-CM:
-
Hypoxic cultured human umbilical cord-derived mesenchymal stem cells secretome
- ICAM:
-
Intercellular adhesion molecule
- IDO:
-
Indoleamine 2,3-dioxygenase
- IFN-γ:
-
Interferon gamma
- IGF:
-
Insulin-like growth factors
- IL:
-
Interleukins
- IL18BP:
-
IL18 binding protein
- IL-1Ra:
-
Interleukin-1 receptor antagonist
- iPSC:
-
Human induced pluripotent stem cell
- KGF :
-
Keratinocyte growth factor
- LAP:
-
Latency-associated protein
- LCMS:
-
Liquid chromatography–mass spectrometry
- LCMS:
-
Liquid chromatography-mass spectrometry
- LIF:
-
Leukemia inhibitory factor
- LIGHT:
-
Tumor necrosis factor superfamily member 14
- L-MSC-S:
-
Limbal mesenchymal stem cell secretome
- LSC-Exo:
-
Lung spheroid cell exosomes
- LSC-sec:
-
Lung spheroid cell secretomes
- MCP-1:
-
Monocyte chemoattractant protein-1
- MDK:
-
Midkine
- MMP:
-
Matrix metalloproteinases
- MSC:
-
Mesenchymal stem cell
- MSC-S:
-
Mesenchymal stem cell–derived secretomes
- MWCO:
-
Molecular weight cut-off
- NGF:
-
Nerve growth factor
- NGF:
-
Nerve growth factor
- NO:
-
Nitric oxide
- NT-:
-
Neurotrophin-
- NT-3:
-
Neurotrophin 3
- PBS:
-
Phosphate buffered saline
- PDGF:
-
Platelet-derived growth factor
- PD-L:
-
Programmed death-ligand
- PEDF:
-
Pigment epithelium-derived factor
- PGE2:
-
Prostaglandin E2
- PGF:
-
Placental growth factor
- PNX-canine model:
-
Pneumonectomy-induced lung injury in a canine model
- PVA:
-
Poly vinyl alcohol
- rBMSC:
-
Rat bone marrow stromal cells
- rOBI:
-
Repetitive ocular blast injury
- RV:
-
Resveratrol
- SDF-1:
-
Stromal cell-derived factor 1
- SD-MSC-S:
-
Skin-derived mesenchymal stem cell secretome
- SOD:
-
Superoxide dismutase
- SPH-MYO:
-
Spheroid-myoblast-conditioned media
- STC1:
-
Stanniocalcin-1
- TCA:
-
Trichloroacetic acid
- TF:
-
Tissue factor
- TGF:
-
Transforming growth factor
- TGF-β1:
-
Transforming growth factor -β1
- TIMP:
-
Metallopeptidase inhibitor
- TNF-α:
-
Tumor necrosis factor alpha
- TSG-6:
-
Tumor necrosis factor stimulated gene 6
- VEGF:
-
Vascularendothelial growth factor
- vWF:
-
vonWillebrand factor
- WJ:
-
Wharton’s jelly
- αMEM:
-
Alpha-minimum essentials medium
References
Almadani YH, Vorstenbosch J, Davison PG, Murphy AM (2021) Wound healing: a comprehensive review [review]. Semin Plast Surg 35(03):141–144. https://doi.org/10.1055/s-0041-1731791
American Lung Association (2021) Pulmonary rehabilitation. https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/pulmonary-rehabilitation
Anjo SI, Lourenço AS, Melo MN, Santa C, Manadas B (2016). Unraveling mesenchymal stem cells’ dynamic secretome through nontargeted proteomics profiling. In M. Gnecchi (Ed.), Mesenchymal Stem Cells: Methods and Protocols (pp. 521–549). Springer New York. https://doi.org/10.1007/978-1-4939-3584-0_32
Astaridewi D, Komaratih E, Rindiastuti Y, Wirohadidjojo Y, Legowo D, Lestari NM, Dewi D, Satya I, Rantam F, Prakoeswa C (2020) Topical instillation of resveratrol preconditioned Wharton’s jelly mesenchymal stem cell secretome preserves ocular surface in experimental model of severe dry eye disease. Open Access Maced J Med Sci 8:1116–1123. https://doi.org/10.3889/oamjms.2020.5305
Bakota EL, Wang Y, Danesh FR, Hartgerink JD (2011) Injectable multidomain peptide nanofiber hydrogel as a delivery agent for stem cell secretome. Biomacromol 12(5):1651–1657. https://doi.org/10.1021/bm200035r
Berezo M, Budman J, Deutscher D, Hess CT, Smith K, Hayes D (2022) Predicting chronic wound healing time using machine learning [article]. Adv Wound Care 11(6):281–296. https://doi.org/10.1089/wound.2021.0073
Blanco-Fernandez B, Castano O, Mateos-Timoneda MA, Engel E, Perez-Amodio S (2021) Nanotechnology approaches in chronic wound healing [article]. Adv Wound Care 10(5):234–256. https://doi.org/10.1089/wound.2019.1094
Bogatcheva NV, Coleman ME (2021) Concentrated secretome of adipose stromal cells limits influenza A virus-induced lung injury in mice. Cells 10(4). https://doi.org/10.3390/cells10040720
Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20(5):1053–1067. https://doi.org/10.1681/asn.2008070798
Bruno S, Deregibus MC, Camussi G (2015) The secretome of mesenchymal stromal cells: role of extracellular vesicles in immunomodulation. Immunol Lett 168(2):154–158. https://doi.org/10.1016/j.imlet.2015.06.007
Burja B, Barlič A, Erman A, Mrak-Poljšak K, Tomšič M, Sodin-Semrl S, Lakota K (2020) Human mesenchymal stromal cells from different tissues exhibit unique responses to different inflammatory stimuli. Curr Res Transl Med 68(4):217–224. https://doi.org/10.1016/j.retram.2020.05.006
Byron O, Nischang I, Patel TR (2018) Analytical ultracentrifugation (AUC): a seminal tool offering multiple solutions. Eur Biophys J 47(7):693–696. https://doi.org/10.1007/s00249-018-1333-z
Carter K, Lee HJ, Na K-S, Fernandes-Cunha GM, Blanco IJ, Djalilian A, Myung D (2019) Characterizing the impact of 2D and 3D culture conditions on the therapeutic effects of human mesenchymal stem cell secretome on corneal wound healing in vitro and ex vivo. Acta Biomater 99:247–257. https://doi.org/10.1016/j.actbio.2019.09.022
Caseiro AR, Pereira T, Ivanova G, Luís AL, Maurício AC (2016) Neuromuscular regeneration: perspective on the application of mesenchymal stem cells and their secretion products. Stem Cells Int 2016:9756973. https://doi.org/10.1155/2016/9756973
Catanzano O, Quaglia F, Boateng JS (2021) Wound dressings as growth factor delivery platforms for chronic wound healing [review]. Expert Opin Drug Deliv 18(6):737–759. https://doi.org/10.1080/17425247.2021.1867096
Centers for Disease Control and Prevention (2021a) Pneumonia. https://www.cdc.gov/pneumonia/index.html
Centers for Disease Control and Prevention (2021b) Vaccines for your children. https://www.cdc.gov/vaccines/parents/diseases/child/pneumo.html
Chen R, Williamson S, Fulton KM, Twine SM, Li J (2019) Simultaneous analysis of phosphopeptides and intact glycopeptides from secretome with mode switchable solid phase extraction. Anal Methods 11(41):5243–5249. https://doi.org/10.1039/C9AY01756A
Chhoy P, Brown CW, Amante JJ, Mercurio AM (2021) Protocol for the separation of extracellular vesicles by ultracentrifugation from in vitro cell culture models. STAR Protocols 2(1):100303. https://doi.org/10.1016/j.xpro.2021.100303
Clabaut A, Grare C, Léger T, Hardouin P, Broux O (2015) Variations of secretome profiles according to conditioned medium preparation: the example of human mesenchymal stem cell-derived adipocytes. Electrophoresis 36(20):2587–2593
Czapla J, Matuszczak S, Kulik K, Wiśniewska E, Pilny E, Jarosz-Biej M, Smolarczyk R, Sirek T, Zembala MO, Zembala M, Szala S, Cichoń T (2019) The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells. Stem Cell Res Ther 10(1):235. https://doi.org/10.1186/s13287-019-1331-9
Dane DM, Cao K, Zhang YA et al (2020) Inhalational delivery of induced pluripotent stem cell secretome improves postpneumonectomy lung structure and function. J Appl Physiol (1985) 129(5):1051–1061. https://doi.org/10.1152/japplphysiol.00205.2020
Daneshmandi L, Shah S, Jafari T, Bhattacharjee M, Momah D, Saveh-Shemshaki N, Lo KWH, Laurencin CT (2020) Emergence of the stem cell secretome in regenerative engineering [review]. Trends Biotechnol 38(12):1373–1384. https://doi.org/10.1016/j.tibtech.2020.04.013
Daskalaki E, Pillon NJ, Krook A, Wheelock CE, Checa A (2018) The influence of culture media upon observed cell secretome metabolite profiles: the balance between cell viability and data interpretability. Anal Chim Acta 1037:338–350. https://doi.org/10.1016/j.aca.2018.04.034
Davies LC, Heldring N, Kadri N, Le Blanc K (2017) Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells 35(3):766–776. https://doi.org/10.1002/stem.2509
Dehkordi MB, Madjd Z, Chaleshtori MH, Meshkani R, Nikfarjam L, Kajbafzadeh A-M (2016) A simple, rapid, and efficient method for isolating mesenchymal stem cells from the entire umbilical cord. Cell Transplant 25(7):1287–1297. https://doi.org/10.3727/096368915x582769
Dinh P-UC, Paudel D, Brochu H, Popowski KD, Gracieux MC, Cores J, Huang K, Hensley MT, Harrell E, Vandergriff AC, George AK, Barrio RT, Hu S, Allen TA, Blackburn K, Caranasos TG, Peng X, Schnabel LV, Adler KB, Cheng K (2020) Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat Commun 11(1):1064. https://doi.org/10.1038/s41467-020-14344-7
Eriksson E, Liu PY, Schultz GS, Martins-Green MM, Tanaka R, Weir D, Gould LJ, Armstrong DG, Gibbons GW, Wolcott R, Olutoye OO, Kirsner RS, Gurtner GC (2022) Chronic wounds: treatment consensus. Wound Repair Regen 30(2):156–171. https://doi.org/10.1111/wrr.12994
Fan X-L, Zhang Y, Li X, Fu Q-L (2020) Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci 77(14):2771–2794. https://doi.org/10.1007/s00018-020-03454-6
Fathi-Kazerooni M, Fattah-Ghazi S, Darzi M, Makarem J, Nasiri R, Salahshour F, Dehghan-Manshadi SA, Kazemnejad S (2022) Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II. Stem Cell Res Ther 13(1):96. https://doi.org/10.1186/s13287-022-02771-w
Ferlin KM, Kaplan DS, Fisher JP (2016) Separation of mesenchymal stem cells through a strategic centrifugation protocol. Tissue Eng Part C Methods 22(4):348–359. https://doi.org/10.1089/ten.tec.2015.0408
Fernandes-Cunha GM, Na KS, Putra I, Lee HJ, Hull S, Cheng YC, Blanco IJ, Eslani M, Djalilian AR, Myung D (2019) Corneal wound healing effects of mesenchymal stem cell secretome delivered within a viscoelastic gel carrier [article]. Stem Cells Transl Med 8(5):478–489. https://doi.org/10.1002/sctm.18-0178
Ferreira JR, Teixeira GQ, Santos SG, Barbosa MA, Almeida-Porada G, Gonçalves RM (2018) Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning [review]. Front Immunol 9. https://doi.org/10.3389/fimmu.2018.02837
Galya I, Tiago P, Ana Rita C, Petia G, Ana Colette M (2016) Metabolomic and proteomic analysis of the mesenchymal stem cells’ secretome. In K. P. Jeevan (Ed.), Metabolomics (pp. Ch. 3). IntechOpen. https://doi.org/10.5772/66101
Giridhar G, Manepalli RKNR, Apparao G (2017) Chapter 3 - size-exclusion chromatography. In S. Thomas, R. Thomas, A. K. Zachariah, & R. K. Mishra (Eds.), Thermal and Rheological Measurement Techniques for Nanomaterials Characterization (pp. 51–65). Elsevier. https://doi.org/10.1016/B978-0-323-46139-9.00003-7
Global Initiative for Asthma (2020) Global strategy for asthma management and prevention. https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf
Global Initiative for Asthma (2021) Global strategy for asthma management and prevention. https://ginasthma.org/gina-reports/
Global Initiative for Chronic Obstructive Lung Disease (2021) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf
Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11(4):367–368. https://doi.org/10.1038/nm0405-367
Gorgun C, Ceresa D, Lesage R, Villa F, Reverberi D, Balbi C, Santamaria S, Cortese K, Malatesta P, Geris L, Quarto R, Tasso R (2021) Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs). Biomaterials 269, 120633. https://doi.org/10.1016/j.biomaterials.2020.120633
Greenbaum D, Luscombe NM, Jansen R, Qian J, Gerstein M (2001) Interrelating different types of genomic data, from proteome to secretome:; oming in on function. Genome Res 11(9):1463–1468. https://doi.org/10.1101/gr.207401
Grover SP, Mackman N (2018) Tissue factor. Arterioscler Thromb Vasc Biol 38(4):709–725. https://doi.org/10.1161/ATVBAHA.117.309846
Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Communication and Signaling 19:47. https://doi.org/10.1186/s12964-021-00730-1
Harman RM, Marx C, Van de Walle GR (2021) Translational animal models provide insight into mesenchymal stromal cell (MSC) secretome therapy [review]. Front Cell Dev Biol 9. https://doi.org/10.3389/fcell.2021.654885
Hee Jung K, Jeong-Soo P (2017) Usage of human mesenchymal stem cells in cell-based therapy: advantages and disadvantages. Dev Reprod 21(1):1–10. https://doi.org/10.12717/DR.2017.21.1.001
Hodge JG, Robinson JL, Mellott AJ (2023) Mesenchymal stem cell extracellular vesicles from tissue-mimetic system enhance epidermal regeneration via formation of migratory cell sheets. Tissue Eng Regen Med 20(6):993–1013. https://doi.org/10.1007/s13770-023-00565-6
Hsieh J-Y, Wang H-W, Chang S-J, Liao K-H, Lee IH, Lin W-S, Wu C-H, Lin W-Y, Cheng S-M (2013) Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS ONE 8(8):e72604. https://doi.org/10.1371/journal.pone.0072604
Jha KA, Gentry J, Del Mar NA, Reiner A, Sohl N, Gangaraju R (2021) Adipose tissue-derived mesenchymal stem cell concentrated conditioned medium alters the expression pattern of glutamate regulatory proteins and aquaporin-4 in the retina after mild traumatic brain injury. J Neurotrauma 38(12):1702–1716. https://doi.org/10.1089/neu.2020.7309
Jha KA, Rasiah PK, Gentry J, Del Mar NA, Kumar R, Adebiyi A, Reiner A, Gangaraju R (2022) Mesenchymal stem cell secretome protects against oxidative stress-induced ocular blast visual pathologies. Exp Eye Res 215:108930. https://doi.org/10.1016/j.exer.2022.108930
Kaminska A, Wedzinska A, Kot M, Sarnowska A (2021) Effect of long-term 3D spheroid culture on WJ-MSC. Cells, 10(4):719. https://www.mdpi.com/2073-4409/10/4/719
Kashirina DN, Kononikhin AS, Larina IM, Buravkova LB (2019) Secretome of cultured human endothelial cells in simulated microgravity. Bull Exp Biol Med 167(1):35–38. https://doi.org/10.1007/s10517-019-04454-8
Katagiri W, Kawai T, Osugi M, Sugimura-Wakayama Y, Sakaguchi K, Kojima T, Kobayashi T (2017) Angiogenesis in newly regenerated bone by secretomes of human mesenchymal stem cells. Maxillofac Plast Reconstr Surg 39(1):8. https://doi.org/10.1186/s40902-017-0106-4
Kehl D, Generali M, Mallone A, Heller M, Uldry A-C, Cheng P, Gantenbein B, Hoerstrup SP, Weber B (2019) Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential. NPJ Regen Med 4(1):8. https://doi.org/10.1038/s41536-019-0070-y
Khan RS, Dine K, Bauman B, Lorentsen M, Lin L, Brown H, Hanson LR, Svitak AL, Wessel H, Brown L, Shindler KS (2017) Intranasal delivery of a novel amnion cell secretome prevents neuronal damage and preserves function in a mouse multiple sclerosis model. Sci Rep 7(1):41768. https://doi.org/10.1038/srep41768
Kim JH, Green DS, Ju YM, Harrison M, Vaughan JW, Atala A, Lee SJ, Jackson JD, Nykiforuk C, Yoo JJ (2022) Identification and characterization of stem cell secretome-based recombinant proteins for wound healing applications [Original Research]. Front Bioeng Biotechnol 10. https://doi.org/10.3389/fbioe.2022.954682
Kompa AR, Greening DW, Kong AM, McMillan PJ, Fang H, Saxena R, Wong RCB, Lees JG, Sivakumaran P, Newcomb AE, Tannous BA, Kos C, Mariana L, Loudovaris T, Hausenloy DJ, Lim SY (2021) Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction. Cardiovasc Res 117(3):918–929. https://doi.org/10.1093/cvr/cvaa088
Kudinov VA, Artyushev RI, Zurina IM, Lapshin RD, Snopova LB, Mukhina IV, Grinakovskaya OS, Saburina IN (2021) Antimicrobial and regenerative effects of placental multipotent mesenchymal stromal cell secretome-based chitosan gel on infected burns in rats. Pharmaceuticals (Basel) 14(12). https://doi.org/10.3390/ph14121263
Kudinov VA, Artyushev RI, Zurina IM, Zorina ES, Lapshin RD, Snopova LB, Mukhina IV, Saburina IN (2022) Inhaled placental mesenchymal stromal cell secretome from two- and three-dimensional cell cultures promotes survival and regeneration in acute lung injury model in mice. Int J Mol Sci 23(7), 3417. https://www.mdpi.com/1422-0067/23/7/3417
Kupcova Skalnikova H (2013) Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95(12):2196–2211. https://doi.org/10.1016/j.biochi.2013.07.015
Kumar P, Kandoi S, Misra R, Vijayalakshmi S, Rajagopal K, Verma RS (2019) The mesenchymal stem cell secretome: a new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor Rev 46:1–9. https://doi.org/10.1016/j.cytogfr.2019.04.002
Laggner M, Gugerell A, Bachmann C, Hofbauer H, Vorstandlechner V, Seibold M, Gouya G, Peterbauer A, Madlener S, Demyanets S, Sorgenfrey D, Ostler T, Erb M, Mildner M, Ankersmit H (2020) Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products. Stem Cell Res Ther 11. https://doi.org/10.1186/s13287-019-1524-2
Lee WS, Kim HJ, Kim KI, Kim GB, Jin W (2019) Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl Med 8(6):504–511. https://doi.org/10.1002/sctm.18-0122
Liang X, Ding Y, Zhang Y, Tse HF, Lian Q (2014) Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant 23(9):1045–1059. https://doi.org/10.3727/096368913x667709
Liguori TT, Liguori GR, Sinkunas V, Correia CJ, Sil R, Dos Santos C, Camargo CP, Zanoni FL, Aiello VD, Harmsen MC, Moreira LFP (2019) Intrapericardial injection of hydrogels derived from decellularized cardiac extracellular matrix loaded with mesenchymal stromal cells and their secretome: a novel proposal of therapeutic approach to cytostatics-induced dilated cardiomyopathy. Circulation 140(Suppl_1):A12353-A12353. https://doi.org/10.1161/circ.140.suppl_1.12353
Liu F, Hu S, Yang H, Li Z, Huang K, Su T, Wang S, Cheng K (2019) Hyaluronic acid hydrogel integrated with mesenchymal stem cell-secretome to treat endometrial injury in a rat model of Asherman’s syndrome. Adv Healthc Mater 8(14):e1900411. https://doi.org/10.1002/adhm.201900411
Liu K, Veenendaal T, Wiendels M, Ruiz-Zapata AM, van Laar J, Kyranas R, Enting H, van Cranenbroek B, Koenen HJPM, Mihaila SM, Oosterwijk E, Kouwer PHJ (2020) Synthetic extracellular matrices as a toolbox to tune stem cell secretome. ACS Appl Mater Interfaces 12(51):56723–56730. https://doi.org/10.1021/acsami.0c16208
Loy H, Kuok DIT, Hui KPY, Choi MHL, Yuen W, Nicholls JM, Peiris JSM, Chan MCW (2019) Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A(H5N1) virus-associated acute lung injury. J Infect Dis 219(2):186–196. https://doi.org/10.1093/infdis/jiy478
Ma W, Liu C, Wang S, Xu H, Sun H, Fan X (2020) Efficacy and safety of intra-articular injection of mesenchymal stem cells in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Medicine 99(49):e23343. https://doi.org/10.1097/md.0000000000023343
Maacha S, Sidahmed H, Jacob S, Gentilcore G, Calzone R, Grivel J-C, Cugno C (2020) Paracrine mechanisms of mesenchymal stromal cells in angiogenesis. Stem Cells Int 2020:4356359. https://doi.org/10.1155/2020/4356359
Merkhan MM, Shephard MT, Forsyth NR (2021) Physoxia alters human mesenchymal stem cell secretome. J Tissue Eng 12:20417314211056132. https://doi.org/10.1177/20417314211056132
Mizukami A, Thome CH, Ferreira GA, Lanfredi GP, Covas DT, Pitteri SJ, Swiech K, Faca VM (2019) Proteomic identification and time-course monitoring of secreted proteins during expansion of human mesenchymal stem/stromal in stirred-tank bioreactor [original research]. Front Bioeng Biotechnol 7(154). https://doi.org/10.3389/fbioe.2019.00154
Mocchi M, Bari E, Marrubini G, Bonda AF, Perteghella S, Tartara F, Cofano F, di Perna G, Giovannelli L, Mandracchia D, Sorlini M, Garbossa D, Torre ML, Segale L (2021) Freeze-dried mesenchymal stem cell-secretome pharmaceuticalization: optimization of formulation and manufacturing process robustness [article]. Pharmaceutics 13(8):18, Article 1129. https://doi.org/10.3390/pharmaceutics13081129
Moghadam M, Tokhanbigli S, Baghaei K, Farivar S, Asadzadeh Aghdaei H, Zali MR (2020) Gene expression profile of immunoregulatory cytokines secreted from bone marrow and adipose derived human mesenchymal stem cells in early and late passages. Mol Biol Rep 47(3):1723–1732. https://doi.org/10.1007/s11033-020-05264-2
Monika P, Chandraprabha MN, Rangarajan A, Waiker PV, Chidambara Murthy KN (2021) Challenges in healing wound: role of complementary and alternative medicine. Front Nutr 8:791899. https://doi.org/10.3389/fnut.2021.791899
Munoz-Perez E, Gonzalez-Pujana A, Igartua M, Santos Vizcaíno E, Hernandez R (2021) Mesenchymal stromal cell secretome for the treatment of immune-mediated inflammatory diseases: latest trends in isolation, content optimization and delivery avenues. Pharmaceutics 13:1802. https://doi.org/10.3390/pharmaceutics13111802
Mustafa SA, Hoheisel JD, Alhamdani MSS (2011) Secretome profiling with antibody microarrays. Mol Biosyst 7(6):1795–1801. https://doi.org/10.1039/C1MB05071K
Műzes G, Sipos F (2022) Mesenchymal stem cell-derived secretome a potential therapeutic option for autoimmune and immune-mediated inflammatory diseases. Cells 11(15), 2300. https://www.mdpi.com/2073-4409/11/15/2300
National Heart L and Blood Institute (2021b) Mechanical ventilation. https://www.nhlbi.nih.gov/health-topics/mechanical-ventilation
National Heart L and Blood Institute (2021c) What is pulmonary fibrosis? https://www.nhlbi.nih.gov/health-topics/pulmonary-fibrosis
National Heart L and Blood Institute (2021a) COPD. https://www.nhlbi.nih.gov/health-topics/copd
Nickerson JL, Doucette AA (2020) Rapid and quantitative protein precipitation for proteome analysis by mass spectrometry. J Proteome Res 19(5):2035–2042. https://doi.org/10.1021/acs.jproteome.9b00867
Nickerson JL, Dang Z, Miller VA, Little SL, Doucette AA (2022) Organic solvent-based protein precipitation for robust proteome purification ahead of mass spectrometry. JoVE (180):e63503. https://doi.org/10.3791/63503
Ning Z, Hawley B, Seebun D, Figeys D (2014) APols-aided protein precipitation: a rapid method for concentrating proteins for proteomic analysis. J Membr Biol 247(9):941–947. https://doi.org/10.1007/s00232-014-9668-6
Nonnis S, Maffioli E, Zanotti L, Santagata F, Negri A, Viola A, Elliman S, Tedeschi G (2016) Effect of fetal bovine serum in culture media on MS analysis of mesenchymal stromal cells secretome. EuPA Open Proteom 10:28–30. https://doi.org/10.1016/j.euprot.2016.01.005
Pavo N, Zimmermann M, Pils D, Mildner M, Petrási Z, Petneházy Ö, Fuzik J, Jakab A, Gabriel C, Sipos W, Maurer G, Gyöngyösi M, Ankersmit HJ (2014) Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction. Biomaterials 35(11):3541–3550. https://doi.org/10.1016/j.biomaterials.2013.12.071
Phelps J, Sanati-Nezhad A, Ungrin M, Duncan NA, Sen A (2018) Bioprocessing of mesenchymal stem cells and their derivatives: toward cell-free therapeutics. Stem Cells Int 2018:9415367. https://doi.org/10.1155/2018/9415367
Pieróg J, Fytianos K, Tamò L, Simillion C, Taddeo A, Kocher G, Gugger M, Grodzki T, Heller M, Blank F, Geiser T, Schmid RA, Gazdhar A (2019) Stem cell secretome attenuates acute rejection in rat lung allotransplant. Interact Cardiovasc Thorac Surg 28(5):812–818. https://doi.org/10.1093/icvts/ivy306
Pinho AG, Cibrão JR, Lima R, Gomes ED, Serra SC, Lentilhas-Graça J, Ribeiro C, Lanceros-Mendez S, Teixeira FG, Monteiro S, Silva NA, Salgado AJ (2022) Immunomodulatory and regenerative effects of the full and fractioned adipose tissue derived stem cells secretome in spinal cord injury. Exp Neurol 351:113989. https://doi.org/10.1016/j.expneurol.2022.113989
Ridzuan N, Zakaria N, Widera D, Sheard J, Morimoto M, Kiyokawa H, Mohd Isa SA, Chatar Singh GK, Then K-Y, Ooi G-C, Yahaya BH (2021) Human umbilical cord mesenchymal stem cell-derived extracellular vesicles ameliorate airway inflammation in a rat model of chronic obstructive pulmonary disease (COPD). Stem Cell Res Ther 12(1):54. https://doi.org/10.1186/s13287-020-02088-6
Robert AW, Azevedo Gomes F, Rode MP, Marques da Silva M, Veleirinho M, Maraschin M, Hayashi L, Wosgrau Calloni G, Stimamiglio MA (2019) The skin regeneration potential of a pro-angiogenic secretome from human skin-derived multipotent stromal cells. J Tissue Eng 10:2041731419833391. https://doi.org/10.1177/2041731419833391
Saccu G, Menchise V, Gai C, Bertolin M, Ferrari S, Giordano C, Manco M, Dastrù W, Tolosano E, Bussolati B, Calautti E, Camussi G, Altruda F, Fagoonee S (2022) Bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles promote corneal wound repair by regulating inflammation and angiogenesis. Cells 11(23):3892. https://www.mdpi.com/2073-4409/11/23/3892
Saeedi P, Halabian R, Imani Fooladi AA (2019) A revealing review of mesenchymal stem cells therapy, clinical perspectives and modification strategies. Stem Cell Investig 6:34–34. https://doi.org/10.21037/sci.2019.08.11
Saiz AM, Gionet-Gonzales MA, Lee MA, Leach JK (2019) Conditioning of myoblast secretome using mesenchymal stem/stromal cell spheroids improves bone repair. Bone 125:151–159. https://doi.org/10.1016/j.bone.2019.05.018
Santamaria G, Brandi E, Vitola PL, Grandi F, Ferrara G, Pischiutta F, Vegliante G, Zanier ER, Re F, Uccelli A, Forloni G, de Rosbo NK, Balducci C (2021) Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice. Cell Death Differ 28(1):203–218. https://doi.org/10.1038/s41418-020-0592-2
Sears V, Ghosh G (2020) Harnessing mesenchymal stem cell secretome: effect of extracellular matrices on proangiogenic signaling. Biotechnol Bioeng 117(4):1159–1171. https://doi.org/10.1002/bit.27272
Serra F, Aielli L, Costantini E (2021) The role of miRNAs in the inflammatory phase of skin wound healing [review]. AIMS 5(4):264–278. https://doi.org/10.3934/Allergy.2021020
Serra SC, Costa JC, Assunção-Silva RC, Teixeira FG, Silva NA, Anjo SI, Manadas B, Gimble JM, Behie LA, Salgado AJ (2018) Influence of passage number on the impact of the secretome of adipose tissue stem cells on neural survival, neurodifferentiation and axonal growth. Biochimie 155:119–128. https://doi.org/10.1016/j.biochi.2018.09.012
Shin TH, Kim HS, Kang TW, Lee BC, Lee HY, Kim YJ, Shin JH, Seo Y, Won Choi S, Lee S, Shin K, Seo KW, Kang KS (2016) Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis 7(12):e2524. https://doi.org/10.1038/cddis.2016.442
Shin S, Lee J, Kwon Y, Park K-S, Jeong J-H, Choi S-J, Bang SI, Chang JW, Lee C (2021) Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose, bone marrow, placenta and Wharton’s jelly. Int J Mol Sci 22(2):845. https://doi.org/10.3390/ijms22020845
Stavely R, Nurgali K (2020) The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl Med 9(9):985–1006. https://doi.org/10.1002/sctm.19-0446
Straits Research (2021) Acellular therapy market share, trends and forecast to 2030. https://straitsresearch.com/report/acellular-therapy-market
Teixeira FG, Salgado AJ (2020) Mesenchymal stem cells secretome: current trends and future challenges. Neural Regen Res 15(1):75–77. https://doi.org/10.4103/1673-5374.264455
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach J-M, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Zuba-Surma EK (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750. https://doi.org/10.1080/20013078.2018.1535750
Tjalsma H, Bolhuis A, Jongbloed JD, Bron S, van Dijl JM (2000) Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol Mol Biol Rev 64(3):515–547. https://doi.org/10.1128/MMBR.64.3.515-547.2000
Torensma R, Prins H-J, Schrama E, Verwiel ETP, Martens ACM, Roelofs H, Jansen BJH (2013) The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells. Stem Cells and Development 22(7):1086–1096. https://doi.org/10.1089/scd.2012.0384
Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R (2017) Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci 18(9):1852. https://www.mdpi.com/1422-0067/18/9/1852
Vriend L, van Dongen JA, Sinkunas V, Brouwer LA, Buikema HJ, Moreira LF, Gemperli R, Bongiovanni L, de Bruin A, van der Lei B, Camargo CP, Harmsen MC (2022) Limited efficacy of adipose stromal cell secretome-loaded skin-derived hydrogels to augment skin flap regeneration in rats. Stem Cells Dev 31(19–20):630–640. https://doi.org/10.1089/scd.2022.0003
Wang PH, Huang BS, Horng HC, Yeh CC, Chen YJ (2018) Wound healing. J Chin Med Assoc 81(2):94–101. https://doi.org/10.1016/j.jcma.2017.11.002
Wangler S, Kamali A, Wapp C, Wuertz-Kozak K, Häckel S, Fortes C, Benneker LM, Haglund L, Richards RG, Alini M, Peroglio M, Grad S (2021) Uncovering the secretome of mesenchymal stromal cells exposed to healthy, traumatic, and degenerative intervertebral discs: a proteomic analysis. Stem Cell Res Ther 12(1):11. https://doi.org/10.1186/s13287-020-02062-2
Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M, Kwong A, Mitsialis SA, Kourembanas S (2018) Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am J Respir Crit Care Med 197(1):104–116. https://doi.org/10.1164/rccm.201705-0925OC
Winkel A, Jaimes Y, Melzer C, Dillschneider P, Hartwig H, Stiesch M, von der Ohe J, Strauss S, Vogt PM, Hamm A, Burmeister L, Roger Y, Elger K, Floerkemeier T, Weissinger EM, Pogozhykh O, Müller T, Selich A, Rothe M, Hoffmann A (2020) Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissues. Cytotherapy 22(11):653–668. https://doi.org/10.1016/j.jcyt.2020.07.005
Wu Y, Chen L, Scott PG, Tredget EE (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25(10):2648–2659. https://doi.org/10.1634/stemcells.2007-0226
Wu JY, Li YJ, Hu XB, Huang S, Xiang DX (2021) Preservation of small extracellular vesicles for functional analysis and therapeutic applications: a comparative evaluation of storage conditions. Drug Deliv 28(1):162–170. https://doi.org/10.1080/10717544.2020.1869866
Xiong F, Yao Z, Chen P, Sun Q, Zhong H, Wan C, Zeng Y (2020) Comparative secretome profile analysis of cultured immortalized human endometrial stromal cells supplemented with implanted versus nonimplanted blastocyst-conditioned medium: a preliminary analysis. J Obstet Gynaecol Res 46(9):1809–1818. https://doi.org/10.1111/jog.14359
Xu C, Diao YF, Wang J, Liang J, Xu HH, Zhao ML, Zheng B, Luan Z, Wang JJ, Yang XP, Wei MG, Duan JH, Wang KQ, Chen C, Chen F, Ming D, Zhang S, Sun HT, Li XH (2020) Intravenously infusing the secretome of adipose-derived mesenchymal stem cells ameliorates neuroinflammation and neurological functioning after traumatic brain injury. Stem Cells Dev 29(4):222–234. https://doi.org/10.1089/scd.2019.0173
Xu Z, Lin L, Fan Y, Huselstein C, De Isla N, He X, Chen Y, Li Y (2022) Secretome of mesenchymal stem cells from consecutive hypoxic cultures promotes resolution of lung inflammation by reprogramming anti-inflammatory macrophages. Int J Mol Sci 23(8). https://doi.org/10.3390/ijms23084333
Yang Y, Wu Y, Yang D, Neo SH, Kadir ND, Goh D, Tan JX, Denslin V, Lee EH, Yang Z (2023) Secretive derived from hypoxia preconditioned mesenchymal stem cells promote cartilage regeneration and mitigate joint inflammation via extracellular vesicles. Bioact Mater 27:98–112. https://doi.org/10.1016/j.bioactmat.2023.03.017
Yen BL, Hsieh C-C, Hsu P-J, Chang C-C, Wang L-T, Yen M-L (2023) Three-dimensional spheroid culture of human mesenchymal stem cells: offering therapeutic advantages and in vitro glimpses of the in vivo state. Stem cells Transl Med 12(5):235–244. https://doi.org/10.1093/stcltm/szad011
Zhou H, Yuen PS, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, Gross P, Knepper MA, Star RA (2006) Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 69(8):1471–1476. https://doi.org/10.1038/sj.ki.5000273
Zhukareva V, Obrocka M, Houle JD, Fischer I, Neuhuber B (2010) Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine 50(3):317–321. https://doi.org/10.1016/j.cyto.2010.01.004
Funding
This review is prepared as part of the collaborative work under the Fundamental Research Grant Scheme (FRGS) project funded by the Ministry of Higher Education Malaysia (Project no: DP KPT FRGS/1/2021/SKK06/UM/02/4).
Author information
Authors and Affiliations
Contributions
Conceptualization: NABNA, WSWKZ and NNR. Drafting and revising: NABNA, VV, WSWKZ, NNR, FN and GJT.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Noor Azlan, N.A.B., Vitus, V., Nor Rashid, N. et al. Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application. Cell Tissue Res 395, 227–250 (2024). https://doi.org/10.1007/s00441-023-03857-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-023-03857-4